BIT 0.00% 3.2¢ biotron limited

Open AccessArticleNew Anti SARS-Cov-2 Targets for Quinoline...

  1. 229 Posts.
    lightbulb Created with Sketch. 355

    Open AccessArticleNew Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine†

    ......not crucial for virus multiplication, the absence of E protein showed an accumulation of probably aberrant virions [78]. Its interaction with PALS1, a particular class of tight junction-associated protein, has been associated with damage to lung epithelium [79]. E protein may represent a novel strategy used by SARS-CoV to increase its virulence [80], and, although it is not involved in the innate immune response to SARS-CoV, it might have an important role in developing a vaccine strategy as well as might be an important target for a chemotherapeutic approach

    New paper out of Italy this morning,although focused on Hydroxy,points to the importance of the E-protein as a target for Covid, which (to me) suggests BIT is still on the right track!

    https://www.mdpi.com/1422-0067/21/16/5856/htm

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $17.40K 542.8K

Buyers (Bids)

No. Vol. Price($)
1 17000 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 120000 2
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.